Bull, base and bear scenarios, opening on what this business has actually done — its realised growth rates and its own P/E range, not round numbers we chose.
Projections are part of Pro
Set the growth, margin and multiple yourself and watch the price land where your assumptions put it — for Cytosorbents Corporation and every other company we cover.
Try it first on NVDA, AAPL, META, NKE or CAKE, where it is open to everyone.
$4.83-17.0%Nov 13 close
The latest quarter (ended September 30, 2026) is from Cytosorbents’s earnings press release of November 12, 2026. It will be replaced by the official quarterly report (10-Q) once Cytosorbents files it.